Clinical Trial Update: Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a triple inhaled therapy consisting of Fluticasone, Formoterol, and Glycopyrronium for chronic obstructive pulmonary disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone/Formoterol/Glycopyrronium (Fluticasone propionate; Formoterol; Glycopyrronium (glycopyrrolate))

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: NOT_YET_RECRUITING